Clinical Trial

Informing Implementation of a Circadian-Focused Intervention for Postpartum Depression

Recruiting
View on ClinicalTrials.gov →
Summary
The proposed study is an open-label trial of Re-Timer® wearable morning bright light therapy for postpartum depression. The study is focused on evaluating the feasibility, acceptability, and implementation context of morning Bright Light Treatment (mBLT) for postpartum depression.
Trial Details
NCT Number NCT07766161
Lead Sponsor University of Michigan
Collaborators: American Academy of Sleep Medicine
Conditions Postpartum Depression (PPD)
Enrollment 30 participants
Start Date 2026-07-29
Primary Completion 2027-05 (estimated)
Study Completion 2027-05 (estimated)
Updated on ClinicalTrials.gov 2026-08-14